CN219142858U - Detection card for rapidly detecting influenza A virus in saliva - Google Patents
Detection card for rapidly detecting influenza A virus in saliva Download PDFInfo
- Publication number
- CN219142858U CN219142858U CN202222450477.2U CN202222450477U CN219142858U CN 219142858 U CN219142858 U CN 219142858U CN 202222450477 U CN202222450477 U CN 202222450477U CN 219142858 U CN219142858 U CN 219142858U
- Authority
- CN
- China
- Prior art keywords
- influenza
- saliva
- virus
- detection
- pad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model provides a detection card for rapidly detecting influenza A virus in saliva, which relates to the technical field of infectious virus detection, and comprises a saliva liquid suction head, a sample pad, a colloidal gold pad, a nitrocellulose reaction membrane, a water absorption pad and a plastic card.
Description
Technical Field
The utility model relates to the technical field of biological detection, in particular to a detection card for rapidly detecting influenza A virus in saliva.
Background
Human influenza is mainly caused by influenza a virus and influenza b virus. In particular, influenza a virus has a very high frequency of antigenic variation and is rapidly transmitted mainly by droplets in the air, contact between susceptible and infected persons, or contact with contaminated articles, and is the main cause of recurrent pandemic of stage influenza. Typical clinical symptoms of influenza a are acute hyperthermia, general pain, significant debilitation and respiratory symptoms, severe ones can cause pneumonia and even be life threatening. The common real-time quantitative fluorescent PCR nucleic acid detection reagent for influenza A virus is limited by complicated operation, long time consumption, cost and the like, and cannot be popularized and applied on a large scale, and the common rapid detection means generally aim at swab samples, the swab samples need training, are relatively difficult to operate, and result errors are easily caused by improper sampling. Therefore, the development of the rapid detection method for the influenza A virus by taking saliva as a sample has important significance for timely blocking the pandemic of the influenza virus and maintaining the life health of vast people.
Disclosure of Invention
The utility model provides a detection card for rapidly detecting influenza A virus in saliva to solve the problems.
In order to solve the technical problems, the technical scheme of the utility model is as follows: a detection card for rapidly detecting influenza A virus in saliva comprises a saliva liquid suction head, a sample pad, a colloidal gold pad, a nitrocellulose reaction membrane, a water absorption pad and a plastic card;
the saliva imbibition head, the sample pad, the colloidal gold pad, the nitrocellulose reaction membrane and the water absorption pad are sequentially stuck on the plastic card, and the colloidal gold pad contains a colloidal gold marked influenza A antibody I.
Further, the nitrocellulose reaction membrane is provided with a detection line and a quality control line, the detection line is positioned on one side of the nitrocellulose reaction membrane, which is close to the colloidal gold pad, the detection line is coated with an influenza A virus antibody II, and the quality control line is positioned on one side of the nitrocellulose reaction membrane, which is far away from the colloidal gold pad, and contains a goat anti-mouse IgG polyclonal antibody.
Further, the influenza A virus antibody I and the influenza A virus antibody II are antibodies with different epitopes, and the antibodies are prepared manually.
Further, saliva is taken as a detection sample by the detection card.
The utility model has the following beneficial effects: the detection card for rapidly detecting the influenza A virus in saliva can specifically identify the influenza A virus, saliva is used as a detection sample, the sample is easy to obtain, a sampling swab is not needed, the influenza A virus detection flow can be simplified, the operation is simple and convenient, the detection period is short, and the judgment is easy.
Drawings
FIG. 1 is a front view of a test card for rapid detection of influenza A virus in saliva according to the present utility model;
FIG. 2 is a positive schematic diagram of the detection result of a detection card for rapidly detecting influenza A virus in saliva;
FIG. 3 is a negative schematic diagram of the detection result of the detection card for rapidly detecting influenza A virus in saliva;
fig. 4 (1) and 4 (2) are schematic diagrams showing that the detection result of the detection card for rapidly detecting influenza a virus in saliva is invalid.
As shown in the figure: 1. a saliva suction head; 2. a sample pad; 3. a colloidal gold pad; 4. a nitrocellulose reaction membrane; 5. a water absorbing pad; 6. a plastic card; t, detecting lines; C. and a quality control line.
Detailed Description
The utility model is further illustrated by the following specific examples, which are intended to illustrate the problem and to explain the utility model, without limiting it.
Example 1
A detection card for rapidly detecting influenza A virus in saliva is shown in figure 1, and comprises a saliva liquid suction head 1, a sample pad 2, a colloidal gold pad 3, a nitrocellulose reaction membrane 4, a water absorption pad 5 and a plastic card 6; in this embodiment, the saliva suction head 1, the sample pad 2, the colloidal gold pad 3, the nitrocellulose reaction membrane 4 and the water absorption pad 5 are sequentially adhered to the plastic card 6, and the colloidal gold pad is a colloidal gold pad containing a colloidal gold-labeled influenza a antibody one; in this embodiment, the nitrocellulose reaction membrane is provided with a detection line T and a quality control line C, the detection line T is located at one side of the nitrocellulose reaction membrane 4 close to the colloidal gold pad 3, the detection line T is coated with influenza a virus antibodies two, and the quality control line C is located at one side of the nitrocellulose reaction membrane 4 away from the colloidal gold pad 3 and contains goat anti-mouse IgG polyclonal antibodies; in this embodiment, the influenza a virus antibody a and the influenza a virus antibody b are antibodies with different epitopes, and the antibodies are all prepared manually.
The application mode of the utility model is as follows:
1) Collecting a sufficient amount of saliva sample;
2) The saliva suction head 1 is contacted with the saliva sample for at least 2 minutes, wherein the saliva suction head 1 of the detection card can be immersed into the saliva sample, and the saliva sample moves towards the water absorption pad 5 along each attachment on the plastic card 6 in sequence;
3) When liquid appears in the observation window, the liquid is placed on a clean and flat workbench, and the detection result of the influenza A virus in the saliva sample is obtained after 15 minutes.
If the saliva sample contains influenza a virus, the saliva sample specifically binds with the colloidal gold labeled influenza a virus antibody on the detection card to form a complex, and then proceeds, and in the process of passing through the nitrocellulose membrane 4, the saliva sample specifically binds with the influenza a virus antibody 2, a red color appears at the detection line T, which indicates that the sample to be detected is positive, and refer to fig. 2.
If the saliva product does not contain influenza A virus, the detection line T does not appear red, and the sample is negative; and the colloidal gold labeled influenza A virus antibody 1 continues to advance to be combined with the goat anti-mouse IgG polyclonal antibody, and the red color appears at the C band of the quality control line, referring to FIG. 3;
whether the sample contains influenza A virus or not, the colloidal gold labeled influenza A virus antibody 1 can continuously move to the quality control line C and combine with the goat anti-mouse IgG polyclonal antibody coated on the quality control line C to form a red strip, namely the quality control line. If the quality control line does not appear in the detection process, the failure or misoperation of the detection card is proved, the result is invalid, and the detection needs to be re-performed, and the two results shown as 4 (1) and 4 (2) in fig. 4 are referred to.
The foregoing is merely a preferred embodiment of the utility model, and it should be noted that modifications could be made by those skilled in the art without departing from the principles of the utility model, which modifications would also be considered to be within the scope of the utility model.
Claims (4)
1. A detection card for rapidly detecting influenza a virus in saliva, which is characterized in that: comprises a saliva suction head (1), a sample pad (2), a colloidal gold pad (3), a nitrocellulose reaction membrane (4), a water absorption pad (5) and a plastic card (6);
the saliva pipette head (1), the sample pad (2), the colloidal gold pad (3), the nitrocellulose reaction membrane (4) and the water absorption pad (5) are sequentially stuck to the plastic card (6), and the colloidal gold pad (3) is provided with a colloidal gold marked influenza A antibody I.
2. A test card for rapid detection of influenza a virus in saliva as defined in claim 1, wherein: the detection line (T) is positioned on one side of the nitrocellulose reaction membrane (4) close to the colloidal gold pad (3), the detection line (T) is coated with influenza A virus antibodies II, and the quality control line (C) is positioned on one side of the nitrocellulose reaction membrane (4) far away from the colloidal gold pad (3) and contains goat anti-mouse IgG polyclonal antibodies.
3. A test card for rapid detection of influenza a virus in saliva as defined in claim 2, wherein: the influenza A virus antibody I and the influenza A virus antibody II are antibodies with different epitopes, and the antibodies are prepared by manpower.
4. A test card for rapid detection of influenza a virus in saliva as defined in claim 1, wherein: the detection card takes saliva as a detection sample.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202222450477.2U CN219142858U (en) | 2022-09-16 | 2022-09-16 | Detection card for rapidly detecting influenza A virus in saliva |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202222450477.2U CN219142858U (en) | 2022-09-16 | 2022-09-16 | Detection card for rapidly detecting influenza A virus in saliva |
Publications (1)
Publication Number | Publication Date |
---|---|
CN219142858U true CN219142858U (en) | 2023-06-06 |
Family
ID=86565822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202222450477.2U Active CN219142858U (en) | 2022-09-16 | 2022-09-16 | Detection card for rapidly detecting influenza A virus in saliva |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN219142858U (en) |
-
2022
- 2022-09-16 CN CN202222450477.2U patent/CN219142858U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010526297A5 (en) | ||
CN111337669A (en) | Novel coronavirus detection test paper and detection method for rapid detection | |
CN210534159U (en) | Microfluidic immunofluorescence kit for novel coronavirus excrement detection | |
CN111273003A (en) | 2019-nCoV novel coronavirus rapid detection immunochromatographic test strip | |
CN112129937A (en) | Novel coronavirus (COVID-19) antigen detection kit and detection method thereof | |
WO2023035617A1 (en) | Fast testing structure integrating sampling and testing and application thereof | |
CN111458499A (en) | Novel detection kit and detection method for coronavirus and influenza virus | |
CN111505276A (en) | Novel coronavirus IgG/IgM antibody detection kit and detection method thereof | |
CN219142858U (en) | Detection card for rapidly detecting influenza A virus in saliva | |
KR20170046166A (en) | Nozzle cap for specimen test container, and specimen test container and specimen test kit using same | |
CN218824309U (en) | Influenza A and B virus and novel coronavirus double-channel saliva detection card | |
CN216117640U (en) | Sampling and detection integrated rapid detection structure | |
CN201464479U (en) | Immune body immunochromatography joint inspection kit for EA- IgG and VCA- IgA of EB viruses | |
CN216209190U (en) | Rapid detection structure for liquid phase sample sampling and detection | |
CN219142859U (en) | Detection card for rapidly detecting influenza A and B virus infection | |
JP4769171B2 (en) | Body fluid sample filtration separation apparatus and method | |
CN210347665U (en) | African swine fever virus micro-fluidic detector | |
CN206420885U (en) | A kind of mycoplasma pneumoniae IgM antibody detection kit | |
CN113899897A (en) | Rapid detection structure for liquid phase sample sampling and detection and application thereof | |
CN1700006A (en) | Avian influenza virus piezoelectric biological sensor detecting instrument | |
CN214750358U (en) | Novel immunochromatography saliva detection kit | |
CN112485425A (en) | Kit for detecting N-S antigen of novel salivary coronavirus and application method thereof | |
CN220894323U (en) | Saliva influenza A virus nucleoprotein rapid detection structure | |
US20220120741A1 (en) | SARS-CoV2 Antigen Lateral Flow Assay Detection Device and Methods of Using the Same | |
CN220120823U (en) | Novel coronavirus IgG/IgM antibody joint detection kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |